Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.
Mar 5, 2021
0
2
French-Austrian biotech firm Valneva said Wednesday it will begin clinical trials of its COVID-19 vaccine candidate in Britain, where the government has already ordered at least 60 million doses.
Dec 16, 2020
0
2
A study conducted by an international team of researchers with FAPESP's support shows that infection by chikungunya virus can produce even more severe manifestations than the typical symptoms of the disease, such as acute ...
Nov 4, 2020
0
3
A deadly combination of two mosquito-borne viruses may be a trigger for stroke, new research published in the The Lancet Neurology has found.
Sep 18, 2020
1
408
Chikungunya virus, once confined to the Eastern Hemisphere, has infected millions of people in the Americas since 2013, when mosquitoes carrying the virus were discovered in the Caribbean. About half of all people infected ...
Jul 14, 2020
0
3
Using antibodies from recovered patients has been life-saving for other acute infections and should be explored in response to COVID-19, researchers say in the International Journal of Risk & Safety in Medicine.
May 12, 2020
0
1
Originally from Africa, chikungunya is aptly named. It derives from a word in the Kimakonde language meaning "to become contorted," because the severe muscle and joint pains endured by the patients prevent them from moving ...
Sep 25, 2019
0
25
Computational tools applied to biology are revolutionizing the study of what happens inside cells during an infection, helping scientists to understand disease mechanisms and contributing to the identification of potential ...
Sep 17, 2019
0
4
Ethiopia's second largest city, Dire Dawa, is dealing with a chikungunya fever outbreak. Around 20,000 cases of the mosquito-borne viral infection have been reported since the outbreak started in March 2019. This is the second ...
Sep 16, 2019
0
2
A new method for permanently marking cells infected with chikungunya virus could reveal how the virus continues to cause joint pain for months to years after the initial infection, according to a study published August 29 ...
Aug 29, 2019
0
2
